The combinatory effects of low glucose and elevated ketones, in tandem with the application of Hyperbaric Oxygen Therapy, three days per week at 2.5AT, for 90 minutes each session, demonstrates remarkable tumor response, absent any toxicity.
Hence, this combination of chronic metabolic control alongside intermittent pro-oxidant therapy in the form of HBOT, constitutes a key pillar of Dr. Seyfried's Press/Pulse protocol.
Notably, the scientific literature demonstrates that glucose and ketone control alone significantly downregulates tumor growth and increases mean survival time.
Crucially, while HBOT as a solitary intervention does not influence cancer progression, combining chronic glucose and ketone control with HBOT elicits a significant decrease in tumor growth rate, increasing mean survival time beyond what a given single intervention offers.
With this understanding in mind, one can begin to strategize as to what a longitudinally viable means of sustainably and non-toxically managing cancer can look like, both with, and absent, the Standard of Care.